Publications by authors named "Sevil Sadri"

Claim this Profile
C
Clinical practice of the endothelial activation and stress index and its modified versions in multiple myeloma and the effects on prognosis.
Vildan Gursoy, Ozgur Omer Gul, Elif Kose, Sevil Sadri

Ther Adv Hematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arterial Thrombosis in Patients with Primary Immune Thrombocytopenia: A Nationwide Study.
Ufuk Demirci, Elif Gülsüm Ümit, Burak Dumludağ, Melda Cömert, Rafiye Çiftçiler, Sevil Sadri

Turk J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and interpretation of the Triple A model in Turkish myeloproliferative neoplasm patients with a focus on overall and thrombosis free survival.
Mehmet Baysal, Sevil Sadri, Özgür Ömer Gül, Elif Köse, Serap Baysal

J Hematop· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis and Validation of the IMPEDED VTE, IMPEDE VTE, and SAVED Risk Models in Predicting Venous Thromboembolism in Multiple Myeloma Patients: A Retrospective Study in Türkiye.
Vildan Gursoy, Mehmet Baysal, Sevil Sadri, Fazil Cagri Hunutlu, Tuba Ersal

Diagnostics (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of Depression, Anxiety, Sleep Quality, and Fatigue in Thalassemia Major Patients: A Study of the Correlation Between Sleep Quality and Laboratory Findings.
Deniz Sener, Sevil Sadri, Vildan Gursoy

Cureus· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Plasma Atherogenic and Triglyceride-Glucose Indices: Markers of Cardiovascular Risk in Transfusion-Dependent Thalassemia.
Nazif Yalcin, Sevil Sadri, Ayşegül Ertınmaz Özkan, Vildan Gürsoy, Nizameddin Koca

Hemoglobin· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HALP score as a novel prognostic factor for patients with myelodysplastic syndromes.
Vildan Gursoy, Sevil Sadri, Hatice Demirci Kucukelyas, Fazıl Cagri Hunutlu, Ibrahim Ethem Pinar

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of acquired and hereditary risk factors for the development of thromboembolism in patients with systemic lupus erythematosus.
Vildan Gürsoy, Sevil Sadri, Selime Ermurat

Blood Coagul Fibrinolysis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do neutrophil-lymphocyte ratio and platelet-lymphocyte ratio have a role in determining mortality in intensive care patients undergoing plasmapheresis? Single-center experience.
Sevil Sadri, Gunes Cavusoglu, Burcu Tunay

Ther Apher Dial· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies.
Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden, Fehmi Hindilerden, Neslihan Andıç, Sevil Sadri, Soğol Sadri

Turk J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare side effect caused by atezolizumab, an immune checkpoint inhibitor: Cold agglutinin disease.
Ozgur Acikgoz, Ayberk Bayramgil, Gunes Cavusoglu, Sevil Sadri

J Oncol Pharm Pract· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience.
Ahmet Emre Eşkazan, Deniz Özmen, Mert Öztaş, Fatih Bektaş, Eşref Alperen Bayraktar, Sevil Sadri

Clin Lymphoma Myeloma Leuk· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoporosis in Patients With Hemophilia: Single-Center Results From a Middle-Income Country.
Serdar Sahin, Sevil Sadri, Zafer Baslar, Muhlis Cem Ar

Clin Appl Thromb Hemost· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience.
Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran, Ali Eser, Tayfur Toptaş, Sevil Sadri

Turk J Haematol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations.
Teoman Soysal, Ahmet Emre Eskazan, Istemi Serin, Sevil Sadri, Dilek Keskin

Clin Lymphoma Myeloma Leuk· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience.
Seniz Öngören, Ayşe Salihoğlu, Tuğçe Apaydın, Sevil Sadri, Ahmet Emre Eşkazan

Balkan Med J· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participation in Physical and Sportive Activities among Adult Turkish People with Hemophilia: A Single-Center Experience.
Arni Lehmeier, Muhlis Cem Ar, Sevil Sadri, Mehmet Yürüyen, Zafer Başlar

Turk J Haematol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.
Ahmet Emre Eskazan, Sevil Sadri, Dilek Keskin, Mesut Ayer, Bulent Kantarcioglu

Clin Lymphoma Myeloma Leuk· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.
Dilek Keskin, Sevil Sadri, Ahmet Emre Eskazan

Drug Des Devel Ther· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collagenous colitis and ileitis under treatment with duloxetine.
Gurhan Sisman, Sevil Sadri, Sebnem Batur, Ahmet Dobrucali

Acta Gastroenterol Belg· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis